Corporate development strategist and growth architect with time-tested performance developing, structuring and closing high-level deals, including M&A, business development and licensing transactions, which have collectively delivered billions of dollars in enterprise value. Visionary leader, with a strong multinational perspective and a proven history of building, leading and empowering teams that have consistently achieved remarkable and innovative results. Expertise across multiple industries includes a strong track record of success in the pharmaceutical/life sciences industry, which is supported by deep network of strategic industry connections and an in-depth understanding of regulatory product approval pathways, both in the US and Europe.